PRDM16 and acute kidney injury: Collectively, these findings reveal that PRDM16 is a novel suppressor of ferroptosis and that targeting PRDM16 using PLGA-encapsulated formononetin represents a new therapeutic strategy for sepsis-induced multiple organ injury, including AKI.